Newest Challenges And Advances In The Treatment Of Colorectal Disorders From Predictive Biomarkers To Minimally Invasive Techniques

Newest Challenges and Advances in the Treatment of Colorectal Disorders; From Predictive Biomarkers to Minimally Invasive Techniques

Colorectal disorders have come to the forefront of modern endoscopic and minimally invasive surgery due to the significant incidence rates and effects on patient quality of life (QoL). Heralded by the rising diagnosis rates of early-onset colorectal cancer, surgical techniques on resection, lymph node harvesting, and bowel anastomosis have been rapidly advancing, in parallel to more minimally invasive approaches such as stenting, tattooing and endoscopic resection. While the role of the colorectal specialist surgeon is central in treating benign and malignant colorectal disease, we must further study the role of novel biomarkers, tumor genomics and proteomics, as well as the use of less invasive methods with regards to the prognosis and outcomes of such patients.

Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer and esophageal cancer, volume II

Recent Advances in Histopathology: 23

Part of the Recent Advnaces series, Histopathology is a collection of comprehensive reviews, with emphasis on breakthroughs and their practical relevance to clinical practice, providing essential reading to help clinicians and trainees remain up to date in the field.